Cargando…

Occurrence of Morpholine in Central Nervous System Drug Discovery

[Image: see text] Developing drugs for the central nervous system (CNS) requires fine chemical modifications, as a strict balance between size and lipophilicity is necessary to improve the permeability through the blood-brain barrier (BBB). In this context, morpholine and its analogues represent val...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lenci, Elena, Calugi, Lorenzo, Trabocchi, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877733/ https://www.ncbi.nlm.nih.gov/pubmed/33459557 http://dx.doi.org/10.1021/acschemneuro.0c00729

Ejemplares similares

Diversity-Oriented Synthesis and Chemoinformatic Analysis of the Molecular Diversity of sp(3)-Rich Morpholine Peptidomimetics
por: Lenci, Elena, et al.
Publicado: (2018)

Peptidomimetic Small-Molecule Inhibitors of 3CLPro Activity and Spike–ACE2 Interaction: Toward Dual-Action Molecules against Coronavirus Infections
por: Tedesco, Filomena, et al.
Publicado: (2022)

Identification of a short ACE2-derived stapled peptide targeting the SARS-CoV-2 spike protein
por: Calugi, Lorenzo, et al.
Publicado: (2023)

Identification of a Common Pharmacophore for Binding to MMP2 and RGD Integrin: Towards a Multitarget Approach to Inhibit Cancer Angiogenesis and Metastasis
por: Baldini, Lorenzo, et al.
Publicado: (2022)

Diversity-Oriented Synthesis as a Tool for Chemical Genetics
por: Lenci, Elena, et al.
Publicado: (2014)

Combination of multicomponent KA(2) and Pauson–Khand reactions: short synthesis of spirocyclic pyrrolocyclopentenones
por: Innocenti, Riccardo, et al.
Publicado: (2020)

Morpholin-4-ium morpholine-4-carbodithioate
por: Mafud, Ana C., et al.
Publicado: (2011)

ADDME – Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective
por: Tsaioun, Katya, et al.
Publicado: (2009)

Identification of Novel Human Breast Carcinoma (MDA-MB-231) Cell Growth Modulators from a Carbohydrate-Based Diversity Oriented Synthesis Library
por: Lenci, Elena, et al.
Publicado: (2016)

Exploring the chemical space and the bioactivity profile of lactams: a chemoinformatic study
por: Saldívar-González, Fernanda I., et al.
Publicado: (2019)

Resolving the age-related decline in central nervous system myelin turnover and drug discovery for oligodendroglial rejuvenation
por: Rivera, Andrea Domenico, et al.
Publicado: (2022)

4-Morpholinecarboxamidine
por: Tiritiris, Ioannis
Publicado: (2012)

Design and Synthesis of Novel Raman Reporters for Bioorthogonal SERS Nanoprobes Engineering
por: Dallari, Caterina, et al.
Publicado: (2022)

Drugs in Central Nervous System Disorders
por: Perry, Bruce D.
Publicado: (1985)

Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery
por: Ghose, Arup K., et al.
Publicado: (2011)

(Morpholin-4-yl)[2-(morpholin-4-yl)-3,5-dinitrophenyl]methanone
por: Gao, Chao, et al.
Publicado: (2012)

Nanomaterials for Drug Delivery to the Central Nervous System
por: Teleanu, Daniel Mihai, et al.
Publicado: (2019)

Morpholin-4-ium hydrogen tartrate
por: Liu, Ming-Liang
Publicado: (2012)

N-Phenylmorpholine-4-carboxamide
por: Meng, Shuang-Ming, et al.
Publicado: (2010)

Morpholine-4-carboxamidinium ethyl carbonate
por: Tiritiris, Ioannis
Publicado: (2012)

The p38α mitogen-activated protein kinase as a central nervous system drug discovery target
por: Borders, Aaron S, et al.
Publicado: (2008)

Occurrence of Spontaneous Tumors in the Central Nervous System (CNS) of F344 and SD Rats
por: Nagatani, Mariko, et al.
Publicado: (2013)

2-[(E)-(Morpholin-4-ylimino)methyl]-6-(morpholin-4-ylmethyl)phenol
por: Akkurt, Mehmet, et al.
Publicado: (2013)

Multilayered Bioorthogonal SERS Nanoprobes Selectively Aggregating in Human Fluids: A Smart Optical Assay for β-Amyloid Peptide Quantification
por: Dallari, Caterina, et al.
Publicado: (2023)

Strategies for Enhanced Drug Delivery to the Central Nervous System
por: Dwibhashyam, V. S. N. M., et al.
Publicado: (2008)

Central nervous system biomarkers for antiobesity drug development()
por: Ziauddeen, Hisham, et al.
Publicado: (2013)

Liposomal Conjugates for Drug Delivery to the Central Nervous System
por: Helm, Frieder, et al.
Publicado: (2015)

Pathogen-inspired drug delivery to the central nervous system
por: McCall, Rebecca L, et al.
Publicado: (2014)

Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions
por: Vatansever, Sezen, et al.
Publicado: (2020)

Central nervous system physiology
por: Rothwell, John, et al.
Publicado: (2021)

4-(4-Nitrophenyl)morpholine
por: Wang, Li-Jiao, et al.
Publicado: (2012)

4-Allylmorpholin-4-ium bromide
por: Han, Meng Ting
Publicado: (2012)

4-(4-Nitrobenzyl)morpholine
por: Yang, Ling-Ling, et al.
Publicado: (2011)

Potassium morpholine-4-carbodithioate monohydrate
por: Mafud, Ana C.
Publicado: (2012)

Morpholine–4-nitrophenol (1/2)
por: Muralidharan, Srinivasan, et al.
Publicado: (2012)

Crystal structure of morpholin-4-ium cinnamate
por: Smith, Graham
Publicado: (2015)

The Central Nervous System
por: De Lorenzi, Davide, et al.
Publicado: (2016)

The Central Nervous System
por: De Lorenzi, Davide, et al.
Publicado: (2010)

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
por: Crowe, Tyler P., et al.
Publicado: (2022)

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
por: DeVos, Sarah L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6hv6i5aphcnhhf6ndss0t3e92u